INS and type 2 diabetes mellitus: T2DM is a chronic disease characterized by two pathophysiological mechanisms: (1) decrease (20%–65%) in the mass and quantity of pancreatic β cells, leading to impaired insulin secretion4; (2) when insulin becomes less effective, cells in muscles, fat and liver fail to respond adequately to insulin.